From Implicit to Explicit: The Operational Impact of the Illinois Health Care Protection Act on Payer Utilization Management

Loading...

Media is loading
 

Document Type

Presentation

Presentation Date

4-7-2026

Comments

Presentation: 43:00

Abstract

Healthcare utilization management has historically been governed by payer-defined medical necessity standards, creating structural conflicts where entities bearing financial risk also determine clinical eligibility. The 2019 Wit v. United Behavioral Health ruling established that medical necessity must align with generally accepted standards of care rather than proprietary payer criteria, catalyzing state legislative action. The Illinois Health Care Protection Act (HCAPA), effective January 1, 2026, mandates alignment of medical necessity criteria with nonprofit specialty society guidelines. This study examines whether HCAPA fundamentally alters payer behavior or displaces cost-containment mechanisms to less-regulated domains. Using Health Care Service Corporation (HCSC) as a case study, this comparative policy analysis employs document analysis and economic modeling to assess coverage policy changes for bariatric surgery and infliximab biosimilars. Results demonstrate simultaneous compliance and displacement. HCAPA eliminated non-evidence-based barriers: HCSC removed mandatory six-month supervised diet requirements for bariatric surgery and Step Therapy protocols for biosimilars. However, utilization management migrated through two mechanisms. First, HCSC's Medical Benefit Therapeutic Alternatives (MBTA) program, launched concurrent with HCAPA, achieves functionally equivalent biosimilar steerage through benefit exclusions rather than prohibited medical necessity determinations, preserving system-level savings estimated at $260–842 million. Second, HCSC exercised Strategic Source Selection, adopting 2019 rather than 2022 bariatric surgery guidelines, maintaining restrictive eligibility for Class I obesity. Economic modeling projects barrier removal increases annual Illinois bariatric procedures from 1,437 to 2,565 (79%), with $35,000 per-patient five-year savings over pharmaceutical management and payer breakeven at 25 months. HCSC voluntarily extended HCAPA-compliant policies across all five operating states, creating regulatory spillover affecting 16–17 million members beyond Illinois jurisdiction. These findings reveal that when regulations constrain specific cost-containment mechanisms, organizations predictably shift those functions to alternative legal domains. Achieving intended access improvements requires comprehensive reform addressing both medical necessity standards and benefit design.

Language

English

This document is currently not available here.

Share

COinS